A detailed history of Allspring Global Investments Holdings, LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Allspring Global Investments Holdings, LLC holds 603,299 shares of HALO stock, worth $28.8 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
603,299
Previous 682,847 11.65%
Holding current value
$28.8 Million
Previous $35.8 Million 3.47%
% of portfolio
0.06%
Previous 0.06%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$51.3 - $64.42 $4.08 Million - $5.12 Million
-79,548 Reduced 11.65%
603,299 $34.5 Million
Q2 2024

Jul 26, 2024

SELL
$37.81 - $52.4 $502,116 - $695,872
-13,280 Reduced 1.91%
682,847 $35.8 Million
Q1 2024

Apr 18, 2024

SELL
$33.68 - $41.95 $1.07 Million - $1.34 Million
-31,871 Reduced 4.38%
696,127 $28.3 Million
Q4 2023

Jan 25, 2024

SELL
$33.32 - $42.1 $5.31 Million - $6.71 Million
-159,276 Reduced 17.95%
727,998 $26.9 Million
Q3 2023

Oct 27, 2023

BUY
$36.46 - $44.03 $32.4 Million - $39.1 Million
887,274 New
887,274 $33.9 Million
Q2 2023

Jul 18, 2023

BUY
$30.28 - $38.74 $2.44 Million - $3.12 Million
80,582 Added 33.2%
323,285 $11.7 Million
Q1 2023

Apr 13, 2023

SELL
$32.86 - $55.7 $5.11 Million - $8.66 Million
-155,513 Reduced 39.05%
242,703 $9.27 Million
Q4 2022

Jan 23, 2023

SELL
$40.06 - $59.44 $13.8 Million - $20.5 Million
-345,471 Reduced 46.45%
398,216 $0
Q3 2022

Oct 26, 2022

BUY
$38.53 - $51.78 $4.53 Million - $6.09 Million
117,645 Added 18.79%
743,687 $29.4 Million
Q2 2022

Jul 25, 2022

SELL
$37.35 - $48.3 $2.72 Million - $3.52 Million
-72,862 Reduced 10.43%
626,042 $27.5 Million
Q1 2022

May 02, 2022

SELL
$31.97 - $41.06 $6.11 Million - $7.84 Million
-191,033 Reduced 21.47%
698,904 $27.9 Million
Q4 2021

Jan 28, 2022

BUY
$31.82 - $40.75 $28.3 Million - $36.3 Million
889,937 New
889,937 $35.8 Million

Others Institutions Holding HALO

About HALOZYME THERAPEUTICS, INC.


  • Ticker HALO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 139,288,992
  • Market Cap $6.66B
  • Description
  • Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...
More about HALO
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.